Ryan V. Hartwell

Inga fler pågående positioner

Health Technology

Consumer Services

Profil

Ryan V.
Hartwell was the founder of Conexeu Sciences, Inc., founded in 2022, where the title held was Chief Executive Officer & Director from 2022 to 2024.
Dr. Hartwell is also the founder of BirchBioMed, Inc...
Dr. Hartwell worked at Mind Cure Health, Inc. as Chief Scientific Officer and Chief Science Officer.
Dr. Hartwell completed a doctorate at the University of British Columbia and an undergraduate degree at the University of Ottawa.

Tidigare kända positioner av Ryan V. Hartwell

Företag	Position	Slut
CONEXEU SCIENCES INC.	Grundare	2024-02-15
LNG ENERGY GROUP CORP.	Teknisk/Vetenskaplig/F&U Direktör	2021-06-04
LNG ENERGY GROUP CORP.	Teknisk/Vetenskaplig/F&U Direktör	-
BirchBioMed, Inc. BirchBioMed, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Grundare	-

Se detaljerna i Ryan V. Hartwells erfarenhet

Ryan V. Hartwells utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Ryan V. Hartwells erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	5
University of British Columbia University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Ottawa University of Ottawa Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
BirchBioMed, Inc. BirchBioMed, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Mind Cure Health, Inc. Mind Cure Health, Inc. Pharmaceuticals: OtherHealth Technology Develops, manufactures, and distributes branded organic functional mushroom powder	Health Technology
CONEXEU SCIENCES INC. CONEXEU SCIENCES INC. BiotechnologyHealth Technology Operates as an early state medical technology company that develops and commercializes novel cellular therapies for skin restoration in wound care and aesthetics	Health Technology